Tribun Health Clinches Best in KLAS Award for the Third Consecutive Year

2 years ago

PARIS, FRANCE and MONTREAL, QC / ACCESSWIRE / February 7, 2024 / Tribun Health, a leading provider of digital pathology…

Tribun Health Clinches Best in KLAS Award for the Third Consecutive Year

2 years ago

PARIS, FRANCE and MONTREAL, QC / ACCESSWIRE / February 7, 2024 / Tribun Health, a leading provider of digital pathology…

Senzime Licensee Fukuda Denshi Launches Integrated TetraGraph Module in Japanese Market

2 years ago

UPPSALA, SE / ACCESSWIRE / February 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions,…

Senzime Licensee Fukuda Denshi Launches Integrated TetraGraph Module in Japanese Market

2 years ago

UPPSALA, SE / ACCESSWIRE / February 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions,…

InfinityRx Appoints Kevin Wong as Chief Technology Officer

2 years ago

Empowering Our Clients With Advanced SolutionsNEW HYDE PARK, NY / ACCESSWIRE / February 7, 2024 / InfinityRx, a copay program…

InfinityRx Appoints Kevin Wong as Chief Technology Officer

2 years ago

Empowering Our Clients With Advanced SolutionsNEW HYDE PARK, NY / ACCESSWIRE / February 7, 2024 / InfinityRx, a copay program…

Two Labs Launches Sunshine Transparency and Aggregate Spend Offering to Provide Transparency Reporting and Compliance Support to the Pharma Industry

2 years ago

COLUMBUS, OH / ACCESSWIRE / February 7, 2024 / Today, Two Labs, an Envision Pharma Company and industry leader in…

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

2 years ago

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule…

Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering

2 years ago

ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing…

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy

2 years ago

MINNEAPOLIS, MN, US, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo")…